Nurix Therapeutics (NRIX) Insider Trading & Ownership

$24.74

-0.09 (-0.36%)

(As of 09/18/2024 ET)

Current Insider Ownership Percentage: 7.20%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 3
Amount Of Insider Selling (Last 12 Months): $1.79 M

Get NRIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NRIX Insider Buying and Selling by Quarter

Ad Darwin

Curious About AI's Next Big Winners? 🚀

Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Download Your Free Report Now]

Nurix Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/3/2024	Christine Ring	Insider	Sell	9,050	$24.94	$225,707.00
8/26/2024	Christine Ring	Insider	Sell	9,870	$25.01	$246,848.70
8/26/2024	Houte Hans Van	CFO	Sell	20,000	$25.22	$504,400.00
8/1/2024	Christine Ring	Insider	Sell	5,760	$21.43	$123,436.80
8/1/2024	Houte Hans Van	CFO	Sell	3,477	$21.45	$74,581.65
7/30/2024	Gwenn Hansen	Insider	Sell	3,408	$20.67	$70,443.36
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover
7/30/2024	Houte Hans Van	CFO	Sell	2,490	$20.67	$51,468.30
7/1/2024	Christine Ring	Insider	Sell	5,760	$20.81	$119,865.60
6/12/2024	Christine Ring	Insider	Sell	1,900	$17.01	$32,319.00
6/5/2024	Christine Ring	Insider	Sell	400	$17.00	$6,800.00
6/3/2024	Christine Ring	Insider	Sell	1,596	$17.01	$27,147.96
5/2/2024	Houte Hans Van	CFO	Sell	3,499	$12.83	$44,892.17
4/30/2024	Gwenn Hansen	Insider	Sell	2,007	$12.04	$24,164.28
4/30/2024	Houte Hans Van	CFO	Sell	1,387	$12.04	$16,699.48
2/16/2024	Houte Hans Van	CFO	Sell	6,812	$10.02	$68,256.24
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66
1/30/2024	Houte Hans Van	CFO	Sell	1,671	$7.99	$13,351.29
12/19/2023	Houte Hans Van	CFO	Sell	10,906	$10.00	$109,060.00
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40
10/31/2023	Houte Hans Van	CFO	Sell	1,080	$5.20	$5,616.00

(Data available from 1/1/2013 forward)

NRIX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Stefani Wolff. Learn more on insiders at NRIX.
: 7.20% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings.
: The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($827,965.18), Gwenn Hansen ($174,299.14), Houte Hans Van ($927,865.90), and Stefani Wolff ($12,881.68).
: Insiders have sold a total of 108,630 Nurix Therapeutics shares in the last 24 months for a total of $1,943,011.90 sold.